2026 International Congress Archives - Page 31 of 208

EAGLE: Protocol for a Phase 3 Study to Evaluate the Efficacy and Safety of Two Mobile Applications Combined with Immediate-Release CD/LD for the Management of Idiopathic Parkinson’s Disease

S. Oren, A. Amedi, S. Molcho, D. Ziv, O. Shoval, S. Erlich (Ramat Gan, Israel)
Early Caudate Dopaminergic Loss as an Imaging Biomarker of Cognitive Impairment in Parkinson’s Disease: A Longitudinal Analysis

B. Panigrahi, D. Radhakrishnan, R. Rajan (Deoghar, India)
Early Clinical Characteristics of Pathologically Confirmed Progressive Supranuclear Palsy and Corticobasal Degeneration

SKS. Ting, S. Asahara Thio, K. Cao, S. Hameed, WS. Li, J. Mukesh Shah, S. Lin, JW. Sim, HJ. Chiew, KP. Ng, ASL. Ng (Singapore, Singapore)
Early Complement Activation Prunes Inhibitory Synapses in Prodromal Synucleinopathy Independent from Lewy Pathology.

S. Rumpf, F. Strübing, K. Nalbach, C. Vargi, S. Lichtenthaler, P. Parchi, P. Gao, W. Chen, M. Brendel, J. Gnörich, A. Bernhardt, G. Höglinger, J. Herms, T. Koeglsperger (Munich, Germany)
Early Descriptions of Sensorimotor Control and Movement Disorders in the Medieval Islamic Golden Age: Insights from Rhazes (Al Razi) and Avicenna (Ibn Sina)

L. Ali (Camerino, Italy)
Early dopaminergic treatment patterns and 5-year survival in Parkinson’s disease: a nationwide observational study

S. Lee, J. Lee, J. Bae, Y. Cho, Y. Hwang, K. Park, J. Oh, J. Kang (Jeju, Republic of Korea)
Early impairment in iTBS-induced cortical plasticity in drug-naïve Parkinson’s disease: a rTMS pilot study

A. Rizzardi, G. Foresti, C. Zatti, K. Eshja, C. Martinuzzo, N. Agostini, A. Pilotto, A. Padovani (Brescia, Italy)
Early integrated Dysphagia and Nutritional Management in Parkinsonism: a prospective Feasibility Study to prevent Malnutrition and Complications

Y. Zashchypas, S. Lorenzl (SAlzburg, Austria)
Early longitudinal changes in non-motor symptoms and routine health checkup parameters around the emergence of prodromal features of Lewy body disease

D. Tamakoshi, K. Hiraga, T. Fukushima, Y. Saito, K. Fuse, T. Uematsu, T. Tsuboi, M. Sato, M. Yamamoto, H. Shimizu, M. Wakai, M. Katsuno (Nagoya, Japan)
Early Manifestations of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) Include Dystonic Laryngeal Phenomena

O. Chan, N. Simon, S. Tisch (Sydney, Australia)
Early Overlap of Corticobasal Syndrome and Richardson Syndrome in Corticobasal Degeneration: Evidence from 252 Autopsy-Confirmed Cases

D. Ono, H. Sekiya, D. Dickson (Tokyo, Japan)
Early Reduction in Cerebral Histamine 3 Receptor Expression in People with Huntington’s Disease: Results from the iMarkHD Study

D. van Wamelen, M. Moretto, J. Badenoch, A. Calvano, P. Eze, M. Hartmann, Z. Kovkasyuk, C. Madrigal-Esquivel, O. Makos, N. Martin, A. Rangel-Cristales, J. Staunton, P. Tall, N. Palasits, A. Wood, F. Turkheimer, M. Veronese, S. Williams (London, United Kingdom)
Early Use of a Conversational Assistant to Interpret Wearable and Patient-Reported Data in Parkinson Disease

B. Hood, S. Shaffer, A. Hare, R. Gilron (San Francisco, USA)
Early-Onset and Familial Parkinson’s Disease in Kyrgyzstan: A PD Cohort Subset for Family-Based Genetic Studies

S. Kyialbekova, E. Zhunusova, C. Shambetova (Bishkek, Kyrgyzstan)
Early-Onset Parkinson Disease in 22q11.2 Deletion Syndrome:Diagnostic Challenges in a Patient With Schizophrenia.A Case Report

L. Salinas-Yañez, J. Altamirano, D. Avecilla-Bonilla, K. Salinas-Barboza (CDMX, Mexico)
Early-Onset Parkinson’s Disease with Early Peak-Dose Dyskinesia: A Case Report

VD. Tkachenko, MZ. Makoeva, MR. Portnova, AV. Nikitina (Moscow, Russian Federation)
Early-Onset Parkinson’s Disease Associated with a Recurrent 16p11.2 Microdeletion Involving PRRT2

N. Jin, X. Zheng, W. Luo (Hangzhou, China)
Early-Onset Parkinson’s Disease Is Associated With Higher Utilization of Deep Brain Stimulation: Real-World Data From a Tertiary Movement Disorders Clinic

M. Arbeu Reyes, M. Rodríguez Violante, A. Cervantes Arriaga (Ciudad de México, Mexico)
Ecological Momentary Assessment Monitoring Captures Motor Fluctuation Improvement after DBS in Parkinson’s Disease

L. Drescher, J. Schikora, L. Feldmann, V. Witzig, P. Nonella, G. Brandt, GH. Schneider, J. Habets, A. Kühn (Berlin, Germany)
EEG-based Functional Connectivity Reveals a Genotype-Specific Network Signature in GBA-Associated Parkinson’s Disease

M. Conti, V. D'Onofrio, M. Avenali, L. Lorenzon, L. Grassi, M. Ginevrino, L. Salviati, M. Terzaghi, M. Carecchio, A. Stefani, EM. Valente, A. Antonini, A. Guerra (Rome, Italy)
Effect of a Live-streaming Tele-exercise in Parkinson’s Disease: a Multicenter, Controlled Trial in South Korea

S. Yoon, J. Ha, J. Youn, J. Cho (Seoul, Republic of Korea)
Effect of ApoE ε4 allele on brain metabolism and cognition in non-demented Parkinson’s disease

JH. Lee, YH. Ryu, CH. Lyoo, HS. Yoo (Seoul, Republic of Korea)
Effect of clonazepam on restless legs syndrome in a multiparous pregnant woman

S. Telarović, L. čondić Jurjević (Zagreb, Croatia)
Effect of deep brain stimulation on quality of life in Parkinson’s disease: a longitudinal analysis of clinical improvement and response probability using mixed-effects models and GEE

MF. Velasco-Delgado, C. Abad-Tinajero, MF. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (Ciudad de México, Mexico)
Effect Of Low Frequency rTMS on Functional Tremor – Objective Evidence From A Single-Session And Longitudinal Observations

D. Santra, S. Banerjee, D. Dutta, S. Karmakar, J. Ganguly, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)
Effect of Poor Sleep Quality on Fatigue Severity in Parkinson’s Disease

N. Helvacı Yılmaz, ö. Köksal, G. İbrahimova, B. Arı, İ. Emekli, G. Yılmaz çakan, M. Samancı, T. Zırh, G. Kenangil (Istanbul, Turkey)
Effect of Random Training–Test Splits on Radiomic Classification of Parkinson’s Disease from T1-Weighted MRI in Machine Learning

S. Mehta, S. Batebi, G. Dumkrieger (Scottsdale, USA)
Effect of subthalamic nucleus deep brain stimulation on heart rate variability in Parkinson’s disease

CH. Sawanon, N. Limotai, N. Suanprasert, CH. Limotai, P. Sathirapanya, S. Rujirussawarawong (Bangkok, Thailand)
Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

Y. Cheng, Y. Huang, J. Ma, J. Yin, X. Dan, J. Qu, Y. Li, G. Zhang, KT. Ustundag, AP. Levin, R. Ribalov, H. Xie, R. Eshet, M. Zeygarnik, J. Wang, H. Shang (Chengdu, China)
Effectiveness aNd use of fosleVOdopa-foscarbidopa in advanced Parkinson disease in real Life setting in France (ENVOL study): interim analysis

O. Colin, A. Marques, S. Montaut, D. Gueguen, MS. Behier, F. Ory Magne (Brive-la-Gaillarde, France)
Effectiveness of Acupuncture for Parkinson’s Disease with Mild Cognitive Impairment A Randomized Clinical Trial

II. Leong, SN. Wu, JQ. Fan, LX. Zhuang (Guangzhou, China)
Effectiveness of Proprioceptive Neuromuscular Facilitation (PNF)-based exercise in people with Pisa syndrome from Parkinson’s disease: a case report

ISK. Wong-Yu, YYE. Chan, HYC. Shiu, PSR. Liu, KY. Cheung (Hong Kong SAR, China)
Effectiveness of Switching from Levodopa-Carbidopa Intestinal Gel to Levodopa-Carbidopa-Entacapone Intestinal Gel in Patients with Refractory Biphasic and Peak-of-Dose Dyskinesia

R. Garcia-Ramos Garcia, A. Fernandez Revuelta, A. Aldaz Burgoa, C. Ribacoba Diaz, A. Alonso Cánovas, I. Parees Moreno, C. Moreno Lopez, JC. Martinez Castrillo (Madrid, Spain)
Effects of a Ballet-Based Intervention on Apathy and Non-Motor Symptoms in Parkinson’s Disease: the PD-BalletTM Randomised Controlled Trial

A. Podlewska, L. Batzu, P. Tall, A. Hartley, A. Woods, C. Pariante, F. Derbyshire-Fox, I. Bakolis, J. Staunton, M. Uribe Mz-Recaman, N. Sevdalis, T. Soukup, V. Leta, A. Woods, D. Fancourt, D. van Wamelen (London, United Kingdom)
Effects of a Motor–Cognitive eHealth‑Supported Home Exercise Program on Walking Difficulties and Performance in Parkinson’s Disease

J. Sedhed, H. Johansson, E. åkesson, E. Franzén, B. Leavy (Huddinge, Sweden)
Effects of a Six-Week Neurorehabilitation Program on Ataxia, Balance and Gait in a Patient with CANVAS Syndrome: A Case Report

M. Salamci, A. Guclu-Gunduz, M. Akbostanci (Ankara, Turkey)
Effects of Auricular Vagus Nerve Stimulation Combined with Neurorehabilitation on Motor Symptoms, Balance, and Gait in People with Parkinson’s Disease: Preliminary Results of a Prospective Study

M. Salamci, A. Guclu-Gunduz, M. Akbostanci (Ankara, Turkey)
Effects of Botulinum Toxin Therapy on Depression, Anxiety, Pain, and Quality of Life in Patients with Dystonia

N. Başpınar, Z. Irmak, A. Ersöz, T. Akıncı, G. Yüksel (Istanbul, Turkey)
Effects of Bright Light Therapy On Sleep And Functional Brain Networks In Parkinson’s Disease-A Pilot Trial

H. Li, Y. Shen, C. Liu (Suzhou, China)
Effects of Chronic IEM-1460 Treatment on Perineuronal Net–Parvalbumin Interneuron Association in L-DOPA-Induced Dyskinesia

NT. Bilbay, EN. Kaptan, C. Cakir-Aktas, G. Yalcin-Cakmakli, B. Elibol, BC. Tel (Ankara, Turkey)
Effects of Dance for Parkinson’s on Disease Severity, Functional Mobility, and Habitual Physical Activity: A Feasibility Study

N. Kalyani, K. Sullivan, G. Moyle, S. Brauer, ER. Jeffrey, G. Kerr (Brisbane, Australia)
Effects of Immersive Gamification Technology on the Physical Function of People with Parkinson’s Disease: A Scoping Review

KI. Guitones, ME. Aguila (Manila, Philippines)
Effects of LSVT BIG on Balance Dysfunction in Parkinson’s Disease and Its Underlying Cortical Regulatory Mechanisms Using fNIRS

X. Zha, P. Liu, J. Wu (Tianjin, China)
Effects of Manual Therapy on Hand Dexterity in Children Aged 4–8 Years: A Prospective Interventional Study

TV. Voloshyn (TRUSKAVETS, Ukraine)
Effects of Modafinil on Motor and Non‑Motor Outcomes in Parkinson’s Disease: A Meta‑Analysis of Randomized, Placebo‑Controlled Trials

A. Lin, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Cincinnati, USA)
Effects of Personalized Visual and Auditory Cueing on Sit-to-Stand Biomechanics in Individuals with Parkinson’s disease: A Subgroup Analysis

N. Charususin, P. Kantha, S. Bovonsunthonchai, R. Rojasavastera, P. Wichaidit, J. Richards, P. Jatesiktat, W. Ang, P. Srivanitchapoom, F. Khobkhun (Nakhon Pathom, Thailand)
Effects of Phase-Specific Vibrotactile Cueing on Spatiotemporal Gait Parameters in Parkinson’s Disease

S. Maddumage Dona, K. Sullivan, A. Lehn, N. Kalyani, G. Kerr (Brisbane City, Australia)
Effects of Psychiatric Symptoms on Dystonia Risk: a Prospective Cohort and Mendelian Randomization Study

X. Zheng, Y. Yu, S. Wang, R. Ou, H. Shang, C. Li (Chengdu, China)
Effects of Repetitive Deep TMS on Motor Function and Cerebral Perfusion in Parkinson’s Disease

B. Kim, M. Chang, I. Song (Seoul, Republic of Korea)
Effects of Rhythmic Auditory Stimulation Combined with LSVT BIG based exercises and Task-Specific Training on Balance and Gait in Parkinson Disease

S. Sambyal, S. Kaur, S. Kumar (Faridkot, India)
Effects of Targeted Memory Reactivation during Sleep on Motor Memory Consolidation in Parkinson’s Disease

L. Micca, G. Albouy, B R. King, A. Nieuwboer, W. Vandenberghe, P. Borzée, B. Buyse, D. Testelmans, J. Nicolas, M. Gilat (Salt Lake City, USA)
Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)
Efficacy and Safety of Ecopipam for Tourette Syndrome: A Meta analysis of Controlled Trials

A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)
Efficacy and Safety of GLP-1 Receptor Agonists in Parkinson’s Disease: A Meta-Analysis Integrating the 96-Week Phase 3 Exenatide Trial Results

K. Sarhan (Mansoura, Egypt)
Efficacy and Safety of Inhaled and Sublingual Apomorphine for On-Demand Treatment of OFF Episodes in Parkinson’s Disease: A Meta‑Analysis of Randomized Placebo‑Controlled Trials

J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Camden, USA)
Efficacy and Safety of Mesdopetam (IRL790) for Levodopa Induced Dyskinesia in Parkinson’s Disease: A Meta analysis of Randomized Controlled Trials

A. Achuthaprasad, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)
Efficacy and Safety of Muscle Afferent Block for Camptocormia in Parkinson’s Disease

S. Horie, K. Matsuura, K. Sakae, A. Shindo (Tsu, Mie, Japan)
Efficacy and safety of single-photon emission computed tomography (SPECT) aided botulinum toxin injection in writers’ cramp: A PROBE Study

A. Das, T. Km, A. Elavarasi, R. Rajan, D. Radhakrishnan, M. Tripathi, M. Tripathi, A. Upadhyay (Delhi, India)
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Gastrointestinal Function in Parkinson’s Disease: A Preliminary Randomized Controlled Trial

Z. Zhu, H. Zhang, H. Wang, Y. Geng, Y. Yuan, K. Zhang (Nanjing, China)
Efficacy of Aripiprazole on Cognitive Functions in Parkinson’s Disease: A Systematic Review and Meta-analysis

I. Serag (Mansoura, Egypt)
Efficacy of Bilateral Ventral Intermediate Nucleus Deep Brain Stimulation in Patients with Neuronal Intranuclear Inclusion Disease-Related Tremor: A Longitudinal Case Series

ZY. Qi, YM. Sun, J. Wang (Shanghai, China)
Efficacy of botulinum toxin treatment for cervical dystonia associated with Parkinson’s disease: A case series.

S. Mian, R. Goel, E. Roddy, V. Holiday, P. Hedera (Louisville, USA)
Efficacy of Combining Outpatient Palliative Care with Standard Care on Quality of Life and Caregiver Burden in Atypical Parkinsonian Syndrome – A Randomised Controlled Trial

R. Kamra, D. Radhakrishnan, N. Gupta, A. Upadhyay, R. Rajan, A. Elavarasi, A. Das, D. Garg, A. Agarwal, A. Pandit, M. Singh, S. Mishra, A. Srivastava (New Delhi, India)
Efficacy of Deutetrabenazine in Patients with Tourette Syndrome: A Meta-Analysis of Randomized Controlled Trials

M. Zanaty, H. Sabet (Qena, Egypt)
Efficacy of Dysport in the treatment of late onset-lingal dystonia secondary to neuroleptics

C. Boukadir (Benaknoun; Algiers, Algeria)
Efficacy of High-Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) for Pain Management in Parkinson’s Disease: A Systematic Review and Meta-Analysis

Y-H. Wu (Taipei, Taiwan)
Efficacy of Mechanoacoustic Vibration Therapy on Motor Function, Bone Density, and Sleep Architecture in Elderly Women with Restless Legs Syndrome

E. -, R. Kumar (New Delhi, India)
Efficacy of Novel Antipsychotic Agents on Cognitive Functions in Parkinson’s Disease: A Systematic Review and Meta-analysis of 2,533 Patients

I. Serag (Mansoura, Egypt)
Efficacy of Opicapone in Early Motor Fluctuations in Parkinson’s Disease: A Comparison of Early versus Later Initiation

JJ. Ferreira, F. Stocchi, A. Antonini, O. Rascol, G. Ebersbach, J. Kulisevsky, MM. Fonseca, D. Ramos, J-F. Rocha, HC. Brigas, J. Holenz, W. Poewe (Lisbon, Portugal)
Efficacy of Rapid-Succession “Flash Song” Music Therapy on Cognitive and Behavioral Symptoms in Outpatients with Juvenile Huntington’s Disease

A. Gangadhar, Y. Dayma (Pune, India)
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Motor Function in Parkinson’s disease; A Prospective, Multicenter, Crossover Study

SJ. Lee, HA. Kim, JE. Kim, MS. Shin, DY. Kown, HW. Shin (Seoul, Republic of Korea)
Efficacy of Vitamin C for Restless Legs Syndrome: A Systematic Review and Meta‑analysis of Randomized Controlled Trials

A. Fornari Caprara, J. Pitton Rissardo, J. Patino, A. Mcgarry, I. Walker (Camden, USA)
Electroacupuncture Restores Cortico-striatal Synaptic Plasticity by Promoting STEP61 against 6-OHDA Induced Extrasynaptic NMDAR/TRPM4 Complex

Y. Zhang, L. Nie, J. Fan, L. Zhuang (Guangzhou, China)
Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis

I. Serag, A. Negida (Mansoura, Egypt)
Electrode implantation outcome evaluation based on diffusion-tensor imaging math processing for PD patients with DBS

A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)
Electrode localization in STN deep brain stimulation using image reconstruction from an emerging DBS program in the Dominican Republic

L. Reyes Lagarde, C. Ramirez Mateo, I. Suero Matos, V. Torres, A. Perez Fernandez, A. Carreras, K. Del Giudice (Santo Domingo, Dominican Republic)
Electroencephalographic and Functional Magnetic Resonance Imaging Analysis of Daytime Sleepiness in Parkinson’s Disease

JR. Zhang, JR. Hou, J. Cheng, XY. Cheng, XJ. Lu, F. Wang, CJ. Mao, CF. Liu (Suzhou, China)
Electronic Health Record Integration Improves Markerless 3D Gait-Based Prediction of Parkinson’s Disease Motor Symptom Severity

L. Lim, K. Kim, Y. Wen, S. Lyu, Y. Shi, K. Mitchell, T. Dunn (Durham, USA)
Electrophysiological Evaluation of Visual Hallucination in Parkinson’s Disease Psychosis

Z. Piazza, G. Schwartz (Stony Brook, USA)
Electrophysiological Signatures of Peak Tremor Frequency Differentiate Parkinson’s Disease, Essential Tremor, and Dystonic Tremor: A Three-Way Comparative Study

V. Thi Hinh, V. Hoang Yen, N. Hai Yen, T. Hue Linh, N. van Lieu (Hanoi, Viet Nam)
Electrophysiological Tremor Analysis In Tremor-Dominant And Postural Instability And Gait Difficulty Phenotypes Of Parkinson’s Disease

L. Truong, H. Vu, Y. Vu, Y. Nguyen, L. Nguyen (Hanoi, Viet Nam)
Elevated Myeloperoxidase Levels and Activity as Potential Biomarkers for Parkinson’s Disease: A Systematic Review and Meta-Analysis

S. Karki, A. Parajuli (Kathmandu, Nepal)
Elucidating the demographic distributions and implications of GBA1 gene variants in Parkinson’s Disease.

F. Fraser, M. Toffoli, G. Pittwood, A. Anderson, J. Stepniak, A. Schapira (London, United Kingdom)
Emergence of Cortical Amyloid from the Prodromal Stage of the Lewy Body Disease Spectrum: Evidence from a PiB-PET Study

M. Yoshita, S. Tsuji, K. Yokoyama (Nanto, Japan)
Emerging Roles for Imaging Techniques in Differentiating Underlying Pathologies in Corticobasal Syndrome

P. Bhaya, D. Petrosyan, N. Nguyen, L. Saadatpour, E. Vaou, S. Horn, P. Coss (San Antonio, USA)
Endogenous reproductive factors and risk of Parkinson’s disease in women: a systematic review and meta-analysis of observational studies

T. Ntetsika, E. Papathoma, T. Soumala, I. Markaki (Stockholm, Sweden)
Engage in Healthy Eating: A Community-Guided Approach to Culturally Sensitive Nutrition Support for People with Parkinson’s Disease (PD)

H. Shah, R. Gilbert, P. Purdy, L. Quinn, A. Parker, E. Adelman, A. Shiell, R. Pena, S. Lim (New York, USA)
Engage-Qatar PD (EQP): Pilot RCT of a Remote Coaching Intervention Using Online Platform to Promote Engagement in Physical Activity in People with Parkinson’s Disease in Qatar.

H. Khalil, M. Abunaib, I. Eltazi, M. Rawash, N. Altaany, T. Alasmar, L. Mohammad, A. Own, S. Pedersen, L. Morris, R. Hammad, M. Qudah, M. Alhatou, S. Koyili, L. Quinn (Doha, Qatar)
Enhancing Neurology Resident Communication of Functional Movement Disorder Using an Artificial Intelligence (AI)-Based Patient Actor

S. Sharma, M. Tanumiharja, K. Fu (Los Angeles, USA)
Enteric Alpha-Synuclein Pathology in Early-Onset Parkinson’s Disease and an Incidental Case in Spinocerebellar Ataxia Type 6

C. Shin, SI. Kim, SH. Park, JM. Kim, JY. Lee, SJ. Chung, JW. Kim, TB. Ahn, KW. Park, JH. Shin, HY. Lee, SH. Kong, YS. Suh, HJ. Kim, B. Jeon (Seongnam-si, Republic of Korea)
Environmental Determinants of Parkinson’s Disease in Saudi Arabia: A Cross-Sectional Study

S. Alshimemeri, A. Aldawood, F. Alabandi, L. Alabdaly, Y. Alsulaim, M. Maashi, S. Bashir, M. Alotaibi, S. Almuammar (Riyadh, Saudi Arabia)
Environmental Risk Factor Co-Exposure as Drivers of Parkinson’s Disease Development: A Scoping Review

A. Mcnamara, K. Daminato, L. Collins-Praino (Adelaide, Australia)
Epidemiology of Parkinson’s Disease and Parkinsonism in Kazakhstan from 2015 to 2024 based on National Health Data

ZH. Myrzayev, G. Saidakhmetova, B. Abdenov, M. Zholdybayeva, A. Muratbaikyzy, G. Mussagaliyeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)
Episodic Memory Impairment in South Asian Individuals with Parkinson’s Disease: A Pilot Comparative Study

A. Oberoi, B. Riad, E. Stenroos, G. Pal (Shreveport, USA)
Equity in Access to Bilateral High Intensity MRI-Guided Focused Ultrasound for Essential Tremor

J. Kim, M. Ferris (Palo Alto, USA)
Escitalopram for Depression and Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta‑analysis

V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)
Establishing the Diagnosis of Wilson’s Disease using the Leipzig Criteria in Patients with Neurological Manifestation: A Single-Center Observation

S. Kumar, S. Shah, C. Kumari, M. Afzal, D. Kumar, N. Bullo (Karachi, Pakistan)
Establishing the Ukrainian Parkinson’s Disease Cohort within GP2: Early Results from the UPGRADE-PD Initiative

S. Bandrivska, H. Houlden, F. Magrinelli, A. Kolodii, V. Bashynska, I. Halushko, Y. Tsyoma, A. Bondarieva, A. Shevchenko, R. Svistilnik, O. Borysenko, O. Kripchak, L. Maksymova, R. Nasalyk, S. Shkrobot, I. Khubetova, A. Cherkez, P. Marushchenko, T. Slobodin (London, United Kingdom)
Evaluating a Decision Aid for Deep Brain Stimulation in Parkinson’s Disease: Results of a Pre–Post Pilot Study

M. Fullard, D. Kern, E. Shelton, A. Dafoe, M. Morris, D. Matlock (Aurora, USA)
Evaluating Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease in the Chinese Population (ADAPT-PD China Study)

H. Shang, B. Sun, J. Wu, Y. Zhang, N. Zhang, A. Xie, L. Chen, J. Zhang, Y. Tan, T. Goble, H. Berrier, S. Stanslaski (Shanghai, China)
Evaluating Bradykinesia in Parkinson’s Disease: Added Value of Monitoring Passive Arm Movement with a Wrist-Worn Wearable Sensor

M. Mijnsbergen, D. Hepp, V. Exadaktylos, J. van Hilten, R. Weijer (Leiden, Netherlands)
Evaluating Environmental, Cognitive and Psychiatric Factors in Pakistani PD patients: London Pakistan Parkinson`s Project (LP-3) Pilot Findings

F. Durrani, Z. Munawar, A. Khan, B. Khan, S. Hamdani, Z. Haq, M. Khan, W. Hafeez, A. Noyce, S. Waris (London, United Kingdom)
Evaluating Gene-Environment Interactions between Head Injury and Parkinson’s Disease Risk Variants.

A. Kuri, S. Waters, L. Jones, N. Del Rey, L. Screven, H. Iwaki, M. Nalls, A. Noyce (London, United Kingdom)
Evaluating Generative AI Systems for Parkinsonism-related counseling: Bridging Accessibility Gaps through AI-Assisted Counseling

C. Lee, M. Kim, Y. Hwang, J. Lee, K. Park, H. Chang, S. Lee, I. Kwak, H. Kim, S. You, J. Yun (Seoul, Republic of Korea)
Evaluating Magnetic Resonance Parkinsonism Index (MRPI) and MRPI 2.0 as Radiographic Metrics to Differentiate Progressive Supranuclear Palsy (PSP) from Normal Pressure Hydrocephalus (NPH)

R. Mani, M. Murphy, C. Zheng, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)
Evaluating Parkinson’s Disease Telehealth in Residential Aged Care

J. Ponce, E. Pepper, E. Collins (New Lambton Heights, Australia)
Evaluating pseudo-monopolar LFP recordings from the STN for optimized DBS contact selection in Parkinson’s disease

A. Vander Weide, V. Witzig, D. Hubers, B. Keulen, J. Schikora, J. Kaplan, A. Memarpouri, L. Drescher, J. Roediger, G. Brandt, R. de Bie, R. Schuurman, M. Beudel, A. Kühn (Amsterdam, North Holland, Netherlands)
Evaluating the Conversion of Immediate-Release and/or Extended-Release Levodopa to IPX203 in Patients with Parkinson’s Disease

L. Poon, A. Lee, D. Lee, T. Chiao, T. Stiep (Stockton, USA)
Evaluating the GBA1 Intronic rs3115534-G PD Risk Variant in the PD GENEration Cohort

A. Dilliott, K. Ghosh Galvelis, N. Bothwick, R. Deleon, M. Dini, M. Thom, D. Anunciacion, E. Trinh, H. Gao, C. Blauwendraat, A. Singleton, J. Beck, R. Alcalay, P. Pdgeneration Study (Miami, USA)
Evaluating the Relationship between Depression and Other Non-Motor Symptoms in Parkinson’s Disease

TCM. Leung, S. Appel-Cresswell (Vancouver, Canada)
Evaluating the Stability of a Short Smell Test in the PREDICT-PD Cohort

S. Meyer, A. Kuri, J. Bestwick, S. Waters, H. Chohan, A. Shahid, L. Smith, C. Simonet, L. Pérez-Carbonell, E. de Pablo-Fernandez, A. Schrag, A. Noyce (London, United Kingdom)
Evaluating YouTube as a source of health information on Parkinson’s disease

KJ. Baladjay, LM. Bagares, RD. Jamora (Manila, Philippines)
Evaluation of Cardiac Markers and Clinical Metrics in Friedreich’s Ataxia

T. Keller, F. Siddiqui, C. Koehring, T. Zesiewicz, K. Zayas, A. Barrios Gonzalez, K. Kim, T. Mcdonald, A. Patel (Tampa, USA)
Evaluation of Electromyographic Measures of Cervical Dystonia Using a 12-Muscle Recording Paradigm

O. Killian, S. Jimenez, A. Gill, C. Fearon, L. Williams, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)
Evaluation of neurosurgical treatment outcomes for tremor using dynamics of tract density and total entropy of the dentatorubrothalamic tract

V. Bayarchyk, A. Buniak, A. Mikitchuk (Minsk, Belarus)
Evaluation of Polygenic Risk Scores Derived from an Updated Cross-European GWAS for Parkinson’s Disease Prediction in European and Ashkenazi Jewish Populations

B. Pizarro-Galleguillos, L. Faria-Costa, M. Isayan, A. Hernández-Medrano, M. Makarious (Belo Horizonte, Brazil)
Evaluation of Semantic Space Search Metrics in Phonemic Fluency: Comparison among Basal Ganglia Disorders and Healthy Controls

S. Kobayashi, Y. Hagiwara, M. Fujimaki, N. Tsutsui, S. Kawaguchi, K. Hasegawa (Tokyo, Japan)
Evaluation of Sleep Parameters in Parkinson’s Disease According to Disease Duration Using Ambulatory Circadian Monitoring

L. Núñez Santos, MF. Valero García, B. Vives Pastor, M. Sastre Mesquida, A. Colomé Menoyo, S. Ferrández Sempere, E. Bargay Pizarro, C. Vallés Serrano, I. Legarda Ramírez (Palma, Spain)
Evaluation of Swallowing and Cough Function in older Patients with Parkinson’s Disease

M. Nakamori, M. Toko, H. Yamada, R. Matsuyama, Y. Hayashi, M. Yoshikawa, T. Nagasaki, H. Maruyama (Hiroshima, Japan)
Event-Locked Characterization of Movement-Related Beta Modulation using Synchronized Local Field Potentials and Video-Based Kinematics

D. Hubers, BJ. Keulen, A. Vander Weide, BCM. van Wijk, PR. Schuurman, RMA. de Bie, M. Beudel (Amsterdam, Netherlands)
Evidence of Systemic and Neuro-Inflammation in Progressive Supranuclear Palsy: Insight from an Imaging-Inflammation Study

S. Dey, A. Kumar, K. Paranthaman, S. Mondal, P. Kumar, P. Pal, R. Yadav, M. Debnath (Bengaluru, India)
Examining the Impact of Fatigue on White Matter tracts in Parkinson’s Disease

JY. Park, E. Morales, J. Bedime, C. Mvomo, S. Perfetto, F. Parent-L’Ecuyer, I. Sierra, H. Lajeunesse, A. Parent, M. Sharp, A. Rochette, A. Potvin-Desrochers, C. Paquette (Montreal, Canada)
Exchangeable copper as a monitoring tool in Wilson disease: lessons from a 24-month prospective cohort

C. Desjardins, N. Djebrani-Oussedik, M. Obadia, D. Rahli, D. Debray, A. Poujois (Paris, France)
Executive Dysfunction as a Determinant of Functional Impairment in Parkinson’s Disease

N. Adhitama, R. Ibonita, R. Puspa, M. Wedariani, A. Devicaesaria, S. Lumempouw (East Jakarta, Indonesia)
Exercise and SUTT: A 9-week randomized, double-blinded, controlled intervention on Parkinsonian Gait.

E. Atterbury, J. Watson-van Zyl, K. Welman (Cape Town, South Africa)
Expanded Parkinson’s Disease GWAS in African Ancestry Populations Identifies Novel Risk Loci and Precision Medicine Targets

N. Okubadejo, O. Ojo, H. Leonard, C. Blauwendraat, A. Singleton, M. Makarious, GP2. Genetics Program (Lagos, Nigeria)
Expanding Parkinson’s Disease Genomics in East Africa

R. Mohammad, E. Nyambane, H. Houlden, J. Hooker, D. Sokhi, P. Adebayo, M. Dekker (London, United Kingdom)
Expanding the Childhood Spectrum of Dentatorubral–pallidoluysian Atrophy: Neuropsychiatric and Motor Phenotypes in Four Siblings

M. Siegel, I. Malaty, A. Ramirez-Zamora (Gainesville, USA)
Expanding the clinical and genetic spectrum of SCA15: a rare case report

M. Shah, K. Shah (Mumbai, India)
Expanding the Clinical Spectrum of 22q11.2 Duplication Syndrome: a 5-year Follow-up of Two Siblings with Young-onset Parkinson’s Disease

A. Milovidov, U. Krikmann (Tartu, Estonia)
Expanding the phenotypic spectrum of FGF14 GAA repeat expansion to paroxysmal kinesigenic dyskinesia

C. Desjardins, A. Méneret, C. Delvallée, E. Leitão, M. Anheim, C. Depienne, E. Roze, T. Wirth (Paris, France)
Expanding the Phenotypic Spectrum of PRRT2 Channelopathy: A Homozygous Mutation With Early Epilepsy, Autism And Dysmorphism In A Consanguineous Family

N. Mishra, M. Bhatt, S. Bidkar, A. Patel (Andheri, India)
Expanding the Spectrum of Non Motor Symptoms in Dystonia: Focus on Autonomic Signs and Pain

P. Antenucci, F. Colucci, A. Gozzi, A. Mechelli, M. Fraccalanza, F. Rovito, M. Pugliatti, E. Sette, D. Gragnaniello, M. Sensi (Ferrara, Italy)
Experiences of Patients with Parkinson’s Disease regarding Pharmacological Treatment in three Peruvian Regions

J. Moya-Salazar, B. Cañari, A. Sobrino (Chiclayo, Peru)
Experiences with Adaptive Deep Brain Stimulation for Parkinson’s Disease in Routine Clinical Care

SS. Vegelin, A. Oswal, D. Ledingham, M. Janssen, A. Querejeta-Coma, K. Balagula, C. Oehrn, A. Macerollo, M. Contarino, G. Oyama, T. Herrington, A. Fasano, B. De-La Casa-Fages, B. Swinnen, G. Tinkhauser, C. Gonzales-Robles, R. Jech, I. Avilés-Olmos, M. Beudel, IAD. Registry Consortium (Amsterdam, Netherlands)
Explainable Machine-Learning Risk Stratification to Identify High-Potential Physical Therapy Responders with Freezing of Gait in Parkinson’s Disease

T-L. Lee, C-Y. Chien, C-C. Lin (Tainan, Taiwan)
Exploratory Efficacy Analysis of Tavapadon Versus MAO-B Inhibitors in People With Early Parkinson’s Disease

E. Freire Alvarez, K. Chan, J. Eubanks, J. Ma, E. Peckham (Alicante, Spain)
Exploratory Quantitative Gait Analysis for Differentiating Parkinson’s Disease from Atypical Parkinsonian Syndromes

T. Jariyasethawong, R. Bhidayasiri, W. Phuenpathom (Bangkok, Thailand)
Exploratory Results From a Phase 1 Study of NIO752 in Progressive Supranuclear Palsy Supporting Further Clinical Studies

M. Brys, M-A. Valentin, S. Menon, N. Pezous, M. Meadowcroft, H. Gunduz-Bruce, C. Serban, L. Kovacic, M-E. Riviere, D. Singh Juneja, A. Graf, L. Vandevrede, G. Höglinger (Basel, Switzerland)
Exploratory study of brain 5-HT4 receptor availability in early-stage Parkinson’s disease

S. Hassen, C. Castano, S. Bourdon, AE. Vallet, A. Lepetit, J. Xie, J. Redoute, V. Sgambato (Vienne, France)
Exploring “sense of muscle contraction” during gluteus maximus training in Parkinson’s disease: a preliminary EMG perception study

J. Ogawa, K. Kakegawa, Y. Sotome, T. Matsuda (Ginza, Chuo-ku, Japan)
Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)
Exploring Demographic Correlates of Diagnostic Interval of Parkinson’s Disease

M. Bienen, O. Biggs-Rodriguez, P. Coss, S. Horn, L. Saadatpour, K. Ghosh-Galvelis, M. Dini, D. Petrosyan, E. Vaou, T. Pd Generation (San Antonio, USA)
Exploring Genetic Contributions to Disease Progression on Hoehn and Yahr Scales in Parkinson’s Disease

L. Jones, N. Kuznetsov, R. Real, E. Navarro-Jones, B. Chase, K. Markopoulou, R. Albin, L. Marsili, C. Lin, L. Pilstrøm,, C. Klein, T. Gasser, T. Anderson, D. Standaert, D. Grosset, M. Hu, B. Warrenburg, W. Berg, H. Morris, H. Iwaki (London, United Kingdom)
Exploring Swallowing Dysfunction, Quality of Life, and Caregiver Burden in Multiple System Atrophy

I. Karagoz, H. Morris, H. Houlden, V. Chelban (London, United Kingdom)
Exploring the Causal Role of Mitochondria-related Genes in Parkinson’s Disease through Multi-Omics Mendelian Randomization

Y. Zhang, M. Niu (Shanghai, China)
Exploring the Genetic Architecture of Parkinson’s Disease in North Africa

S. Hrir, H. Nehdi, T. Lüth, C. Gabbert, A. Fienemann, S. Schaake, T. Kleinz, Y. Kanana, F. Nabli, R. Zouari, D. Ben Mohamed, A. Rachdi, Z. Saied, R. Amouri, M. Farrer, F. Hentati, C. Klein, S. Ben Sassi, J. Trinh, GP2. Genetics Program (Lübeck, Germany)
Exploring the Genetic Landscape of Corticobasal Syndrome in Asian Populations

CY. Liu, PS. Chen, MZ. Hung, NC. Lee, SP. Fan, CH. Lee, CH. Tai, HL. Chiang, CY. Chen, YR. Wu, YY. Chang, CS. Lu, T. Nomura, H. Yaguchi, TS. Toh, AH. Tan, EK. Tan, I. Yabe, SY. Lim, CH. Lin (Taipei, Taiwan)
Exploring the Impact of Parameter Selection on Digital Sleep Outcomes in Parkinson’s Disease: Results from the IDEA-FAST Study

M. Sedghi, S. Del Din, W-F. Ng, W. Maetzler, NV. Manyakov, S. Avey, R. Göder, C. Pinaud, M. Chatterjee, RZ. Ur Rehman, JP. Taylor, L. Alcock, RA. Lawson (Newcastle upon Tyne, United Kingdom)
Exploring the Relationship Between Circadian Disruption, Depression and Suicidal Ideation in People with Huntington’s Disease (Mind & Clock Study)

A. Rangel Cristales, A. Hampshire, D. van Wamelen (London, United Kingdom)
Exploring the Relationship Between Insomnia and Autonomic Dysfunction in Parkinson’s Disease: A 1 Year SCOPA-AUT Analysis

D. Petrosyan, P. Bhaya, P. Coss, S. Horn, E. Vaou, L. Saadatpour (San Antonio, USA)
Exploring the variability in spoken language comprehension, speech and functional communication in children with GNAO1-associated disorder: a case series

L. Heideman, J. Geytenbeek, N. Wolf, A. Buizer, L. Vande Pol (Amsterdam, Netherlands)
Exploring Usability and Feasibility of an Optimised Smartwatch to Monitor Medication Intake in Parkinson’s Disease

E. Packer, K. Scott, P. Brown, J. Sarvestan, A. Smalley, O. Brugna, N. Ireson, V. Lanfranchi, L. Rochester, A. Yarnall, L. Alcock, M. Peeters, S. Del Din (United Kingdom)
Exposure-Response Analysis of Glovadalen in the ATLANTIS Phase II Study: Trial Simulation Explains Dose-Response for OFF Time in Parkinson’s

D. Menshykau, M. Biagioni, C. Beuter, C. Legendre, A. Benoit, L. Vroye, B. Klünder, M. Faisal, S. Leach, R. Nicholl, H. Naik (Monheim am Rhein, Germany)
Extended long-term follow-up of adaptive deep brain stimulation in Parkinson’s disease

T. Herrington, A. Ramirez-Zamora, M. Beudel, S. Little, J. Ostrem, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, N. Sarangmat, M. Gostkowski, L. Tonder, Y. Tan, R. Summers, T. Goble, S. Stanslaski, H. Bronte-Stewart (Boston, USA)
External Validation of a Machine Learning Classifier for Motor Progression in Parkinson’s Disease

A. Vijayakumari, R. Popov, O. Hogue, H. Fernandez, B. Walter (Cleveland, USA)
External Validation of Reported Clinical Predictors of Levodopa-Related Adverse Drug Reactions in Parkinson’s Disease

L. Helling, R. Weijer, J. Swen, S. Böhringer, J. van Hilten, D. Hepp (Leiden, Netherlands)
Extracellular Neuromelanin Promotes Microglial Reactivity in Parkinson’s Disease

S. Smajic, V. Florentin, J. Ghelfi, K. Badanjak, S. Delcambre, C. Morris, J. Schwamborn, M. Spielmann, P. Antony, I. Goglia, A. Grünewald (Belval Esch-sur-Alzette, Luxembourg)
Extracellular Small RNAs in Huntington’s disease: from Brain to CSF Analysis

G. Olmedo-Saura, M. Herrero-Lorenzo, A. Cardona-Collado, A. Puig-Davi, A. Vazquez-Oliver, E. Rivas-Asensio, D. Alcolea, C. Franch-Marti, S. Martinez-Horta, A. Gámez-Valero, J. Kulisevsky, J. Perez Perez, E. Martí (Barcelona, Spain)
Extracellular vesicle–based characterization of synaptic dysfunction in early Parkinson’s disease

L. Kurvits, C. van Riesen, J. Rhee (Göttingen, Germany)